116
Views
7
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

Spectrophotometric Determination of Risedronate and Etidronate in Pharmaceutical Formulations via the Molybdovanadate Method

, , &
Pages 1571-1587 | Received 03 Dec 2008, Accepted 15 Apr 2009, Published online: 26 Jun 2009
 

Abstract

An accurate and sensitive spectrophotometric method was developed for the determination of risedronate and etidronate in pharmaceuticals. The method was based on oxidation of the studied drugs with potassium persulfate and reaction of the generated orthophosphate ions with molybdovanadate reagent. The produced yellow phosphovanadomolybdate complex was measured at 313 nm. The method was rectilinear in the ranges 0.5–10 and 0.5–8 µg/mL with detection limits of 0.087 and 0.122 µg/mL for risedronate and etidronate, respectively. The method was applied for the determination of the studied drugs in their tablets, and the results agreed with those obtained by the comparison methods.

Notes

a Sy/x: standard deviation of the residuals; Sb: standard deviation of the slope; Error = % RSD/√n; Sa, standard deviation of the intercept; and E, molar absorbtivity.

Note. Each result is the average of three separate assays.

Note. Each result is the average of three separate assays.

*Values between brackets are the tabulated t and F values at p = 0.05.

Note. Each result is the average of three separate assays.

*Values between brackets are the tabulated t and F values at p = 0.05.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.